These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25204840)

  • 1. Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency: a case report.
    Varricchio A; Schettino M; Ciampa A; Iannace C; Lo Conte D; Di Libero L; Donnarumma B; Vigorito R; Lepore M
    Ann Ital Chir; 2014 Jun; 85(ePub):. PubMed ID: 25204840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency.
    Varricchio A; Schettino M; Ciampa A; Iannace C; Lo Conte D; Donnarumma B; Vigorito R; Lepore M
    Ann Ital Chir; 2014 Jun; 85(ePub):. PubMed ID: 24980142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
    Wiszniewski A; Szczepanik A; Misiak A; Bykowska K; Szopiński P
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):324-30. PubMed ID: 25688458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Surgical Third Lower Molar Extraction and Postoperative Progress in Patients With Factor VII Deficiency: A Clinical Protocol and Focus on This Rare Pathologic Entity.
    Passarelli PC; Pasquantonio G; D'Addona A
    J Oral Maxillofac Surg; 2017 Oct; 75(10):2070.e1-2070.e4. PubMed ID: 28672139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
    Karimi M
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
    Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
    Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
    Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
    İnce Z; Bulut Ö; Tuğrul-Aksakal M; Ünüvar A; Devecioğlu Ö; Çoban A
    Turk J Pediatr; 2018; 60(5):562-565. PubMed ID: 30968639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
    Miyata N; Isaka M; Kojima H; Maniwa T; Takahashi S; Takamiya O; Ohde Y
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):177-80. PubMed ID: 25056454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report.
    Weinstock RJ; Onyejiuwa A; Shnayder G; Clarkson EI
    J Am Dent Assoc; 2015 Apr; 146(4):271-5. PubMed ID: 25819659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
    Yilmaz AA; Yalcin S; Serdaroglu H; Sonmezer M; Uysalel A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):693-5. PubMed ID: 18832912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful short-term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency.
    Billio A; Pescosta N; Rosanelli C; Amaddii G; Fontanella F; Coser P
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):249-50. PubMed ID: 9199823
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery.
    Wasowicz M; Meineri M; McCluskey SM; Mitsakakis N; Karkouti K
    J Cardiothorac Vasc Anesth; 2009 Dec; 23(6):828-34. PubMed ID: 19467888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
    Mariani G; Dolce A; Batorova A; Auerswald G; Schved JF; Siragusa S; Napolitano M; Knudsen JB; Ingerslev J;
    Br J Haematol; 2011 Feb; 152(3):340-6. PubMed ID: 21158750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.